Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S
Priyanka Bhatia(Department of Biotechnology), Jared Sterneckert(Max Planck Institute for Molecular Biomedicine), Amay A. Agrawal(Technische Universität Dresden), Stefanie N. Vogel(University of Maryland, Baltimore), Björn Falkenburger(German Center for Neurodegenerative Diseases), Ivan Mikičić(Technische Universität Dresden), Arun Pal(Technische Universität Dresden), Andreas Hermann(University Medical Center), Lydia Reinhardt(Technische Universität Dresden), Maximina H. Yun(Center for Systems Biology Dresden), Buster Truss(Technische Universität Dresden), Eva M. Szegoe(Technische Universität Dresden), Kathrin Brockmann(German Center for Neurodegenerative Diseases), Aikaterina Nikolaidi(Technische Universität Dresden), Marc Bickle(Roche (Switzerland))
Cited by 2
Related Papers
Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
|PLoS ONE|2013|473
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation
|Nature Communications|2018|288
Hot-spot KIF5A mutations cause familial ALS
|Brain|2017|231
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
|Mucosal Immunology|2009|166
Platelet-rich fibrin: the benefits
|British Journal of Oral and Maxillofacial Surgery|2015|76